Clinical Trial Update: Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing secukinumab versus placebo on fat tissue and skin in plaque psoriasis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2020-03-10